# US 2023/0263389 A1 · Systems and Methods for Determining Tissue Inflammation Levels

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0263389 A1
- Document ID: US20230263389A1
- Status: Published application
- Kind: A1
- Application number: 18/140,195
- Filed: 2023-04-27
- Published: 2023-08-24
- Earliest claimed: 2019-10-10
- Assignees: Tufts Medical Center, Inc.
- Applicants: Tufts Medical Center, Inc.
- Inventors: Pedram Hamrah; William Warr Binotti; Ricardo Menon Nose
- Web page: https://patentgrep.com/patent/US20230263389A1

## CPC

- A61B 3/102: {for optical coherence tomography [OCT]}
- A61F 9/0017: {implantable in, or in contact with, the eye, e.g. ocular inserts}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

Disclosed are methods, systems, media, apparatus, devices, and other implementations, including a method that includes determining blood flow characteristics at an ocular surface of an eye of a patient, determining characteristics of blood vessels at the ocular surface of the eye based on the determined blood flow characteristics, and deriving one or more ocular redness grading scales indicative of inflammation levels of the eye of the patient based on the determined characteristics of the blood vessels at the ocular surface of the eye.

## Claims

### Claim 1

A method comprising:
determining blood flow characteristics at an ocular surface of an eye of a patient;
determining characteristics of blood vessels at the ocular surface of the eye based on the determined blood flow characteristics; and
deriving one or more ocular redness grading scales indicative of inflammation levels of the eye of the patient based on the determined characteristics of the blood vessels at the ocular surface of the eye.

### Claim 2 (depends on 1)

The method of claim 1, wherein determining the blood flow characteristics at the ocular surface of the eye comprises:
performing anterior segment (AS) optical coherence tomography angiography (OCTA) imaging for the ocular surface to detect blood flow at the ocular surface of the eye.

### Claim 3 (depends on 2)

The method of claim 2, wherein performing AS-OCTA for the ocular surface comprises:
producing images, based on the detected blood flow, representing a vasculature distribution at the ocular surface of the eye.

### Claim 4 (depends on 2)

The method of claim 2, wherein performing AS-OCTA for the ocular surface to detect blood flow at the ocular surface of the eye comprises:
obtaining blood flow image data for multiple layers of the ocular surface, the multiple layers comprise one or more of: cornea, limbus, conjunctiva, episcleral, or sclera.

### Claim 5 (depends on 4)

The method of claim 4, wherein obtaining the blood flow image data the multiple layers further comprises:
dividing the image data for at least one of the multiple layers, based on a respective reference depth for the at least one of the multiple layers, into one or more of a superficial layer image data, deep layer image data, or full thickness image data.

### Claim 6 (depends on 4)

The method of claim 4, further comprising:
separating the blood flow image data into separate blood flow image data sets for one or more of the multiple layers.

### Claim 7 (depends on 6)

The method of claim 6, wherein separating the blood flow image data into separate blood flow image data sets for the respective multiple layers comprises:
separating the blood flow image data into the separate blood flow image data sets using machine learning techniques.

### Claim 8 (depends on 2)

The method of claim 2, wherein performing AS-OCTA imaging for the ocular surface comprises:
controllably adjusting focus of a lens assembly of an OCT imaging apparatus based on one or more of: controllably actuating a focus-motor of the OCT imaging apparatus, or controllably actuating a z-motor of the OCT imaging apparatus to control the distance between the lens assembly and the eye of the patient.

### Claim 9 (depends on 2)

The method of claim 2, wherein performing AS-OCTA imaging for the ocular surface comprises:
controlling an optical emission source of an OCT imaging apparatus to provide optical radiation controllably directed at the ocular surface, including performing one or more of: controllably adjusting the optical radiation directed to the eye of the patient so that light reflectance behavior is affected by tissue at the ocular surface of the eye, or controllably actuating activation and de-activation of the optical emission source provided to the OCT imaging apparatus.

### Claim 10 (depends on 1)

The method of claim 1, wherein determining characteristics of the blood vessels at the ocular surface of the eye comprises:
determining one or more of: vessel density of the blood vessels at the ocular surface, diameters attributes of at least some of the blood vessels, or vasculature branching pattern attributes for the blood vessels measured by fractal dimension.

### Claim 11 (depends on 10)

The method of claim 10, wherein determining the characteristics of the blood vessels at the ocular surface comprises:
obtaining one or more images representative of a vasculature mapping at the ocular surface of the eye based on the determined blood flow characteristics; and
processing the one or more images to determine the characteristics of the blood vessels based on image data from the processed one or more images.

### Claim 12 (depends on 11)

The method of claim 11, wherein processing the one or more images comprises:
identifying pixels, for a particular image from the one or more images, representing blood vessels in the image;
determining a ratio of the identified pixels representing the blood vessels in the image and total number of pixels in the particular image; and
determining the vessel density based on the determined ratio.

### Claim 13 (depends on 12)

The method of claim 12, wherein identifying the pixels comprises:
binarizing the particular image to convert pixels value into either a pre-determined pixel value representing blood flow, or another pre-determine pixel value representing no blood flow.

### Claim 14 (depends on 11)

The method of claim 11, wherein processing the one or more images comprises:
identifying pixels, for a particular image from the one or more images, representing non-vessel objects in the particular image;
generating a skeletonized image corresponding to the particular image comprising skeleton representations of blood vessels appearing in the particular image;
identifying skeletonized pixels, for the skeletonized image, representing non-vessel objects in the skeletonized image; and
deriving a vessel diameter index based on the identified pixels representing the non-vessel objects in the particular image and the identified skeletonized pixels representing the non-vessel objects in the skeletonized image.

### Claim 15 (depends on 11)

The method of claim 11, wherein processing the one or more images comprises:
performing fractal dimension analysis of vessels appearing in the one or more images to determine vasculature branching pattern complexity of the blood vessels at the ocular surface of the eye.

### Claim 16 (depends on 1)

The method of claim 1, further comprising:
determining one or more medical conditions of the patient based on the derived one or more ocular redness measures.

### Claim 17

A system to determine inflammation level of an eye of a patient, the system comprising:
an imaging apparatus to determine blood flow characteristics at an ocular surface of the eye of the patient; and
a controller configured to:
determine characteristics of blood vessels at the ocular surface of the eye based on the determined blood flow characteristics; and
derive one or more ocular redness grading scales indicative of inflammation levels of the eye of the patient based on the determined characteristics of the blood vessels at the ocular surface of the eye.

### Claim 18 (depends on 17)

The system of claim 17, wherein the imaging apparatus comprises an anterior segment (AS) optical coherence tomography angiography (OCTA) imaging apparatus, and wherein the controller configured to determine the blood flow characteristics at the ocular surface of the eye is configured to:
perform AS-OCTA imaging for the ocular surface to detect blood flow at the ocular surface of the eye.

### Claim 19 (depends on 18)

The system of claim 18, wherein the AS-OCTA imaging apparatus is configured to produce images based on the detected blood flow representing a vasculature distribution at the ocular surface of the eye.

### Claim 20 (depends on 18)

The system of claim 18, wherein the controller configured to perform AS-OCTA imaging for the ocular surface to detect blood flow at the ocular surface is configured to:
obtain blood flow image data for multiple layers of the ocular surface, the multiple layers comprise one or more of: cornea, limbus, conjunctiva, episcleral, or sclera; and
separate the blood flow image data into separate blood flow image data sets for: one or more of respective multiple layers, or into one or more of a superficial layer, a deep layer, or full thickness layer.

### Claim 21 (depends on 20)

The system of claim 20, wherein the controller further comprises a machine learning engine configured to separate the blood flow image data into the separate blood flow image data sets based on machine learning techniques.

### Claim 22

The system of 18, wherein the controller to perform AS-OCTA imaging for the ocular surface is configured to:
controllably adjust focus of a lens assembly coupled to an OCT imaging apparatus based on one or more of: controllably actuating a focus-motor of the OCT imaging apparatus, or controllably actuating a z-motor of the OCT imaging apparatus to control the distance between the lens assembly and the eye of the patient.

### Claim 23

The system of 18, wherein the controller to perform AS-OCTA for the ocular surface is configured to:
controllably actuate activation and de-activation of the optical emission source provided to the OCT imaging apparatus.

### Claim 24 (depends on 17)

The system of claim 17, wherein the controller configured to determine characteristics of the blood vessels at the ocular surface of the eye is configured to:
determine one or more of: vessel density of the blood vessels at the ocular surface, diameter attributes of at least some of the blood vessels, or vasculature branching pattern attributes for the blood vessels measured by fractal dimension.

### Claim 25 (depends on 24)

The system of claim 24, wherein the controller configured to determine the characteristics of the blood vessels at the ocular surface is configured to:
obtain one or more images representative of a vasculature mapping at the ocular surface of the eye based on the determined blood flow characteristics; and
process the one or more images to determine the characteristics of the blood vessels based on image data from the processed one or more images.

### Claim 26 (depends on 25)

The system of claim 25, wherein the controller configured to process the one or more images is configured to:
identify pixels, for a particular image from the one or more images, representing blood vessels in the image;
determine a ratio of the identified pixels representing the blood vessels in the image and total number of pixels in the particular image; and
determine the vessel density based on the determined ratio.

### Claim 27 (depends on 25)

The system of claim 25, wherein the controller configured to process the one or more images is configured to:
identify pixels, for a particular image from the one or more images, representing non-vessel objects in the particular image;
generate a skeletonized image comprising skeleton representations of blood vessels appearing in the particular image;
identify skeletonized pixels, for the skeletonized image, representing non-vessel objects in the skeletonized image; and
derive a vessel diameter index based on the identified pixels representing the non-vessel objects in the particular image and the identified skeletonized pixels representing the non-vessel objects in the skeletonized image.

### Claim 28 (depends on 25)

The system of claim 25, wherein the controller configured to process the one or more images is configured to:
perform fractal dimension analysis of vessels appearing in the one or more images to determine vasculature branching pattern complexity of the blood vessels at the ocular surface of the eye.

### Claim 29

Non-transitory computer readable media comprising computer instructions, executable on one or more processor-based devices, to:
determine blood flow characteristics at an ocular surface of an eye of a patient;
determine characteristics of blood vessels at the ocular surface of the eye based on the determined blood flow characteristics; and
derive one or more ocular redness grading scales indicative of inflammation levels of the eye of the patient based on the determined characteristics of the blood vessels at the ocular surface of the eye.
